• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后肠道菌群变化与肠道急性移植物抗宿主病关系的探讨

Exploration of the relationship between intestinal flora changes and gut acute graft-versus-host disease after hematopoietic stem cell transplantation.

作者信息

Song Aiyun, Shen Nan, Gan Chi, Luo Changying, Luo Chengjuan, Wang Jianmin, Cao Qing, Chen Jing

机构信息

Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Infectious Disease, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Transl Pediatr. 2021 Feb;10(2):283-295. doi: 10.21037/tp-20-208.

DOI:10.21037/tp-20-208
PMID:33708514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7944174/
Abstract

BACKGROUND

Acute graft-versus-host disease (aGVHD) is a life-threatening factor for post-hematopoietic stem cell transplantation (HSCT) patients. To investigate the relationship between intestinal flora changes and gut aGVHD after HSCT, we performed this cross-sectional study.

METHODS

We selected children from our medical center from July 2016 to January 2017. Fifty-six samples from 42 patients and 6 samples from normal children met the study criteria and were analyzed. Fecal 16S RNA sequencing was completed before transplantation or on days 7, 28 or 100 post-transplantation. The intestinal infection and GVHD clinical data were retrospectively analyzed, and the survival risk factors were analyzed. Correlation analysis was performed with the feces bioinformatic data.

RESULTS

The GVHD group alpha diversity was the lowest, which was significantly different than that of the non-diarrhea group (P value=0.032). A richer posttransplantation relative abundance of was conducive to survival, while that of and was not. Similarly, a rich relative abundance of , and in the intestinal flora before HSCT contributed to patient death thereafter. Regarding diarrhea, the GVHD group exhibited a richer and relative abundances, which showed strong correlations with diarrhea severity. , and were richer in relative abundance in the intestinal infection group and correlated with pretransplant characteristics.

CONCLUSIONS

The gut microbiota diversity was lowest when gut aGVHD occurred, which was consistent with the clinically higher mortality rate and greater treatment difficulty. played an important role in gut aGVHD and diarrhea severity. led to infectious diarrhea after HSCT. Specific bacteria were biomarkers for survival: , and from the intestinal flora after HSCT and , and before HSCT.

摘要

背景

急性移植物抗宿主病(aGVHD)是造血干细胞移植(HSCT)后患者的一个危及生命的因素。为了研究HSCT后肠道菌群变化与肠道aGVHD之间的关系,我们开展了这项横断面研究。

方法

我们选取了2016年7月至2017年1月在我们医疗中心的儿童。来自42例患者的56份样本和来自正常儿童的6份样本符合研究标准并进行了分析。在移植前或移植后第7、28或100天完成粪便16S RNA测序。对肠道感染和GVHD临床数据进行回顾性分析,并分析生存风险因素。对粪便生物信息数据进行相关性分析。

结果

GVHD组的α多样性最低,与非腹泻组相比有显著差异(P值=0.032)。移植后相对丰度较高的[具体菌群名称未给出]有利于生存,而[具体菌群名称未给出]和[具体菌群名称未给出]则不然。同样,HSCT前肠道菌群中[具体菌群名称未给出]、[具体菌群名称未给出]和[具体菌群名称未给出]的相对丰度较高会导致患者随后死亡。关于腹泻,GVHD组的[具体菌群名称未给出]和[具体菌群名称未给出]相对丰度较高,与腹泻严重程度密切相关。肠道感染组中[具体菌群名称未给出]、[具体菌群名称未给出]和[具体菌群名称未给出]的相对丰度较高,且与移植前特征相关。

结论

肠道aGVHD发生时肠道微生物群多样性最低,这与临床上较高的死亡率和较大的治疗难度一致。[具体菌群名称未给出]在肠道aGVHD和腹泻严重程度中起重要作用。[具体菌群名称未给出]导致HSCT后感染性腹泻。特定细菌是生存的生物标志物:HSCT后肠道菌群中的[具体菌群名称未给出]、[具体菌群名称未给出]和[具体菌群名称未给出]以及HSCT前的[具体菌群名称未给出]、[具体菌群名称未给出]和[具体菌群名称未给出]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/b03903cff6a0/tp-10-02-283-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/a0c67b49d195/tp-10-02-283-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/1be3c4700f62/tp-10-02-283-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/4171c54c06c3/tp-10-02-283-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/de2333921749/tp-10-02-283-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/9bc1a5b811c2/tp-10-02-283-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/d4af2a2a6968/tp-10-02-283-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/b74b9a07ea07/tp-10-02-283-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/b03903cff6a0/tp-10-02-283-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/a0c67b49d195/tp-10-02-283-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/1be3c4700f62/tp-10-02-283-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/4171c54c06c3/tp-10-02-283-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/de2333921749/tp-10-02-283-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/9bc1a5b811c2/tp-10-02-283-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/d4af2a2a6968/tp-10-02-283-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/b74b9a07ea07/tp-10-02-283-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd9/7944174/b03903cff6a0/tp-10-02-283-f8.jpg

相似文献

1
Exploration of the relationship between intestinal flora changes and gut acute graft-versus-host disease after hematopoietic stem cell transplantation.造血干细胞移植后肠道菌群变化与肠道急性移植物抗宿主病关系的探讨
Transl Pediatr. 2021 Feb;10(2):283-295. doi: 10.21037/tp-20-208.
2
The distribution of intestinal flora after hematopoietic stem cell transplantation in children.儿童造血干细胞移植后肠道菌群的分布。
Pediatr Transplant. 2024 Feb;28(1):e14678. doi: 10.1111/petr.14678. Epub 2023 Dec 26.
3
The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.黏膜相关不变 T 细胞在造血干细胞移植后肠道移植物抗宿主病发病机制中的潜在作用。
Front Immunol. 2021 Sep 3;12:720354. doi: 10.3389/fimmu.2021.720354. eCollection 2021.
4
Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植治疗儿童患者口腔和肠道微生物群失调与治疗并发症的相关性研究。
Sci Rep. 2024 Mar 20;14(1):6708. doi: 10.1038/s41598-024-55690-6.
5
The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.异基因造血干细胞移植后肠道微生物组的组成及其与 16S 核糖体 RNA 评估的移植物抗宿主病的关系。
J Physiol Pharmacol. 2023 Feb;74(1). doi: 10.26402/jpp.2023.1.10. Epub 2023 May 23.
6
The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.血必净注射液中的四种主要成分的组合通过保护肠道微环境,提高了环孢素 A 在急性移植物抗宿主病小鼠中的预防效果。
Biomed Pharmacother. 2022 Apr;148:112675. doi: 10.1016/j.biopha.2022.112675. Epub 2022 Feb 17.
7
Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.异基因造血细胞移植治疗血液系统疾病儿童发生移植物抗宿主病的早期肠道微生物组特征。
BMC Med Genomics. 2019 Mar 7;12(1):49. doi: 10.1186/s12920-019-0494-7.
8
Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.特定的肠道微生物群成员与儿科异基因造血干细胞移植中的不同免疫标志物相关。
Microbiome. 2019 Sep 13;7(1):131. doi: 10.1186/s40168-019-0745-z.
9
Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.异基因干细胞移植相关性急性移植物抗宿主病:基于口腔和肠道微生物组特征的计算药物发现文本挖掘方法。
Support Care Cancer. 2021 Apr;29(4):1765-1779. doi: 10.1007/s00520-020-05821-2. Epub 2020 Oct 22.
10
[Clinical Study of Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Children].儿童异基因造血干细胞移植后肠道急性移植物抗宿主病的临床研究
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Apr;30(2):600-606. doi: 10.19746/j.cnki.issn.1009-2137.2022.02.046.

引用本文的文献

1
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.肠道微生物群、微生物衍生代谢物与移植物抗宿主病。
Cancer Med. 2024 Feb;13(3):e6799. doi: 10.1002/cam4.6799. Epub 2024 Jan 18.
2
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.肠道微生物群多样性与异基因造血细胞移植结局的关联:一项系统评价和荟萃分析。
Ann Hematol. 2023 Dec;102(12):3555-3566. doi: 10.1007/s00277-023-05460-7. Epub 2023 Sep 28.
3
Roles of the intestinal microbiota and microbial metabolites in acute GVHD.

本文引用的文献

1
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.异基因造血干细胞移植后进行第三方粪便微生物群移植可重建微生物组多样性。
Blood Adv. 2018 Apr 10;2(7):745-753. doi: 10.1182/bloodadvances.2018017731.
2
Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice.肠道微生物群提供的营养支持可改善骨髓移植后小鼠的造血重建。
Cell Host Microbe. 2018 Apr 11;23(4):447-457.e4. doi: 10.1016/j.chom.2018.03.002. Epub 2018 Mar 22.
3
The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients.
肠道微生物群和微生物代谢产物在急性移植物抗宿主病中的作用。
Exp Hematol Oncol. 2021 Oct 27;10(1):49. doi: 10.1186/s40164-021-00240-3.
巨细胞病毒(CMV)特异性CD8 + T淋巴细胞重建与异基因造血干细胞移植后患者CMV再激活和持续存在风险之间的潜在关联。
Hematology. 2018 Sep;23(8):463-469. doi: 10.1080/10245332.2017.1422686. Epub 2018 Jan 9.
4
Faecal transplantation for IBD management-pitfalls and promises.粪菌移植治疗炎症性肠病:问题与展望。
Br Med Bull. 2017 Dec 1;124(1):181-190. doi: 10.1093/bmb/ldx040.
5
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.Ⅱ级急性移植物抗宿主病和更高的有核细胞移植物剂量可改善环磷酰胺后 HLA 单倍体相合移植后的无进展生存。
Biol Blood Marrow Transplant. 2018 Feb;24(2):343-352. doi: 10.1016/j.bbmt.2017.10.023. Epub 2017 Oct 18.
6
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.粪便微生物群移植治疗儿科造血干细胞移植受者复发性艰难梭菌感染
J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):e6-e8. doi: 10.1093/jpids/pix076.
7
Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.粪便微生物群在中性粒细胞恢复时可预测造血细胞移植后严重急性移植物抗宿主病。
Clin Infect Dis. 2017 Nov 29;65(12):1984-1991. doi: 10.1093/cid/cix699.
8
Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.肠道急性移植物抗宿主病:胃肠病学家需考虑的因素
Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):711-726. doi: 10.1038/nrgastro.2017.126. Epub 2017 Sep 27.
9
Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Infection in a Pediatric Heart Transplant Patient.一名小儿心脏移植患者因反复感染接受粪便微生物群移植后肠道细菌微生物群组成的变化
Front Cardiovasc Med. 2017 Apr 4;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017.
10
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.采用移植后环磷酰胺的非清髓性单倍体相合骨髓移植治疗高危血液系统恶性肿瘤的儿童和青年患者
Biol Blood Marrow Transplant. 2017 Feb;23(2):325-332. doi: 10.1016/j.bbmt.2016.11.016. Epub 2016 Nov 22.